The Progress of Colorectal Polyposis Syndrome in Chinese Population

Abstract

The pathogenesis, clinical phenotype, treatment strategy, and family management of hereditary tumor syndromes are different from those of sporadic tumors. Nearly a quarter of patients with colorectal cancer show significant familial aggregation and genetic predisposition, and 5 to 10% are associated with definite genetic factors. According to the clinical phenotype, it can be divided into nonpolyposis syndrome and polyposis syndrome. Among the polyposis syndrome patients with definite clinical symptoms, there are still some patients with unknown etiology (especially attenuated familial adenomatous polyposis), which is a difficult problem in clinical diagnosis and treatment. Therefore, for this rare disease, it is urgent to carry out multicenter studies, complete the gene variation spectrum, explore new pathogenic factors, and accumulate clinical experience. This article mainly introduces the research progress and related work of colorectal polyposis syndrome in China.

Keywords: colorectal cancer; germline variants; hereditary tumor syndromes; polyposis syndrome.

Fig. 1

APC gene variants and protein level changes in Chinese and global populations. ( A ) APC gene variants in Chinese population; ( B ) APC protein level changes in Chinese population; ( C ) APC gene variants in global population; ( D ) APC protein level changes in global population.